Jeff Knight, Columbia Threadneedle Investments and David Lefkowitz, UBS, weigh in on what's moving markets. » Read More
By: Jim Cramer
CNBC's Jim Cramer explains why he is keeping an eye on shares of Micron and Lam Research. » Read More
Sarah Ketterer, Causeway Capital Management CEO & portfolio manager, and Viraj Patel, ING FX strategist, provide their top plays in stocks and currencies. » Read More
JPMorgan's Marko Kolanovic sees a market correction ahead, and calls it a buying opportunity.
More media deals may be on the table under President Trump and his deregulation plans. CNBC's Julia Boorstin reports. The "Fast Money" traders weigh in.
Kim Wallace, Renaissance Macro Research, weighs in on President Trump's "skinny" budget, including which sectors may benefit from it.
Joel Greenblatt, Gotham Asset Management, discusses where he sees opportunity in the markets.
Cowen maintained its outperform rating on the iPhone maker after results from Jabil Circuit.
Discusses the latest capital raise for Tesla and what deregulation could mean for the electric vehicle industry, with Rob Cihra, Guggenheim Securities, and CNBC's Phil LeBeau.
Gold rallies off the Fed rate hike. Is a rally ahead? With CNBC's Jackie DeAngelis and the Futures Now Traders.
BlackRock's Michael Fredericks on the market, risks and the company's top plays for income. With CNBC's Jackie DeAngelis and the Futures Now traders.
Watch the exclusive PRO Talks discussion between CNBC's Mike Santoli and Deutsche Bank's chief global strategist, Binky Chadha.
What will drive the next rally? Trading S&P futures now, with Ed Yardeni, Yardeni Research, CNBC's Jackie DeAngelis and the Futures Now traders, Scott Nations and Jeff Kilburg, both from the CME.
The new capital raised by Tesla may not be enough to alleviate investors' concerns, UBS says.
Vanguard's Greg Davis weighs in on the Fed's decision to hike rates, and the market's reaction to it. The "Fast Money" traders weigh in.
TJX, owner of T.J. Maxx and HomeGoods, won't feel the same pinch as stores anchored in the local mall, Goldman says.
Dani Reiss, Canada Goose CEO, discusses the outerwear company's IPO and the outlook for its brand.
Biogen shares are fully valued following the spinoff of its hemophilia business, Morgan Stanley argues.
CNBC's Jim Cramer explains why he is watching shares of core portfolio holding, 3M
Jim Cramer is keeping an eye on shares of Snap, and explains why non-voting stock is beginning to look a lot like fantasy brackets.
Jim Cramer spoke with Cullen/Frost CEO Phillip Green about oil prices and the Fed.
Jim Cramer explained his play book for banks in light of an interest rate increase from the Fed.
Jim Cramer dives into CEO stock buybacks and how they can help or hurt investors.